30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,186 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Healthcare Services Mid (5.8bn) -1–5 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (5.7bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.6bn) -1–5 -$100M+ -0–15% 0–15%
DK H Lundbeck A/S (HLUN-A)
Pharmaceuticals & Medical Research Mid (5.6bn) 0 No activity — 0–15%
SE Getinge AB (GETI-B)
Healthcare Services Mid (5.5bn) 1–5 $10M–$100M 0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) -1–5 -$1M–$10M -0–15% 15–50%
Pharmaceuticals & Medical Research Mid (5.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (5.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 15–50%
US LHC Group Inc (LHCG)
Healthcare Services Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.3bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (5.2bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (5.0bn) 0 No activity — 15–50%
GB Indivior PLC (INDV)
Pharmaceuticals & Medical Research Mid (4.9bn) 0 No activity — 0–15%
Healthcare Services Mid (4.7bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Mid (4.7bn) 0 No activity — 0–15%
US Veracyte Inc (VCYT)
Pharmaceuticals & Medical Research Mid (4.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Healthcare Services Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.5bn) 0 No activity — 0–15%
US LivaNova PLC (LIVN)
Healthcare Services Mid (4.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (4.4bn) 0 No activity — 50%+
Healthcare Services Mid (4.4bn) 0 -< $100K 0–15% 0–15%
Healthcare Services Mid (4.4bn) -1–5 -$100M+ -15–50% 0–15%
Healthcare Services Mid (4.4bn) 0 No activity — 50%+
US Erasca Inc (ERAS)
Pharmaceuticals & Medical Research Mid (4.4bn) 0 No activity — 0–15%
US Celcuity Inc (CELC)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.3bn) 1–5 $100K–$1M 0–15% 15–50%
IN Biocon Ltd (BIOCON)
Pharmaceuticals & Medical Research Mid (4.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (4.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (4.2bn) 0 No activity — 0–15%
US RadNet Inc (RDNT)
Healthcare Services Mid (4.2bn) -1–5 -$1M–$10M -0–15% 0–15%
US Alkermes Inc (ALKS)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
US TESARO Inc (TSRO)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — —
US Metsera Inc (MTSR)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
IN Ajanta Pharma Ltd (AJANTPHARM)
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (4.1bn) 0 No activity — 0–15%
Healthcare Services Mid (4.1bn) 1–5 < $100K 0–15% 50%+
Pharmaceuticals & Medical Research Mid (4.0bn) -1–5 -< $100K -0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) 0 No activity — 0–15%
Healthcare Services Mid (3.9bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.9bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.8bn) -1–5 -< $100K -0–15% 0–15%
Healthcare Services Mid (3.8bn) -1–5 -$1M–$10M -0–15% 0–15%
US Perrigo Co (PRGO)
Pharmaceuticals & Medical Research Mid (3.8bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Healthcare Services Mid (3.7bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.7bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mid (3.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.6bn) 0 No activity — 15–50%
Healthcare Services Mid (3.6bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.5bn) -1–5 -< $100K -0–15% 0–15%
US Organon & Co (OGN)
Pharmaceuticals & Medical Research Mid (3.5bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 No activity — 50%+
Healthcare Services Mid (3.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.5bn) 1–5 $1M–$10M 0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.5bn) 0 $100K–$1M 0–15% 0–15%
Healthcare Services Mid (3.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mid (3.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Mid (3.4bn) 0 No activity — 0–15%
Healthcare Services Mid (3.4bn) 0 No activity — 15–50%
SE Medicover AB (MCOV-B)
Healthcare Services Mid (3.4bn) 1–5 < $100K 0–15% 0–15%
Healthcare Services Mid (3.3bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Mid (3.3bn) 0 No activity — 0–15%
US Amedisys Inc (AMED)
Healthcare Services Mid (3.3bn) 0 No activity — 0–15%
Healthcare Services Mid (3.3bn) 0 -$100K–$1M -0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) -1–5 -< $100K -0–15% 0–15%
FR Virbac SA (VIRP)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 50%+
SE BioArctic AB (BIOA-B)
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 15–50%
Healthcare Services Mid (3.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mid (3.2bn) 1–5 $10M–$100M 0–15% 50%+
Pharmaceuticals & Medical Research Mid (3.2bn) 0 No activity — 50%+
Healthcare Services Mid (3.2bn) -1–5 -$1M–$10M -0–15% 15–50%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Mid (3.1bn) -1–5 -$100K–$1M -0–15% 0–15%